Kangmei Group

Corporate VC

Kangmei Pharmaceutical Co., Ltd. — publicly traded (SSE:600518) Chinese traditional-medicine pharmaceutical company (Puning/Shenzhen, Guangdong) making a corporate/strategic investment as new investor "KANGMEI Group" in Twist Bioscience's $27M June 2017 extension round. Not a dedicated VC fund; investor_type=vc likely miscategorizes an operating company's one-off corporate investment.

1+ investments

Total Investment
1
Last Investment
Jun 2017

Overview

Kangmei Group is a Corporate VC firm. It has made 1 investment.

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Kangmei Group on Indexed.vc
<a href="https://indexed.vc/investors/kangmei-group"><img src="https://indexed.vc/api/badge/investor/kangmei-group" alt="Kangmei Group on Indexed.vc" width="260" height="76" /></a>